Annual Accounts Payable
$3.28 M
-$2.71 M-45.29%
December 31, 2023
Summary
- As of February 7, 2025, TRDA annual accounts payable is $3.28 million, with the most recent change of -$2.71 million (-45.29%) on December 31, 2023.
- During the last 3 years, TRDA annual accounts payable has risen by +$1.68 million (+104.56%).
- TRDA annual accounts payable is now -45.29% below its all-time high of $5.99 million, reached on December 31, 2022.
Performance
TRDA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.29 M
-$343.00 K-20.98%
September 30, 2024
Summary
- As of February 7, 2025, TRDA quarterly accounts payable is $1.29 million, with the most recent change of -$343.00 thousand (-20.98%) on September 30, 2024.
- Over the past year, TRDA quarterly accounts payable has increased by +$540.00 thousand (+71.81%).
- TRDA quarterly accounts payable is now -80.04% below its all-time high of $6.47 million, reached on March 31, 2023.
Performance
TRDA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
TRDA Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -45.3% | +71.8% |
| 3 y3 years | +104.6% | -78.4% |
| 5 y5 years | +361.6% | -78.4% |
TRDA Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -45.3% | +364.2% | -80.0% | +83.0% |
| 5 y | 5-year | -45.3% | +364.2% | -80.0% | +83.0% |
| alltime | all time | -45.3% | +364.2% | -80.0% | +83.0% |
Entrada Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.29 M(-21.0%) |
| Jun 2024 | - | $1.64 M(-35.3%) |
| Mar 2024 | - | $2.53 M(-22.9%) |
| Dec 2023 | $3.28 M(-45.3%) | $3.28 M(+335.8%) |
| Sep 2023 | - | $752.00 K(-69.0%) |
| Jun 2023 | - | $2.42 M(-62.6%) |
| Mar 2023 | - | $6.47 M(+8.1%) |
| Dec 2022 | $5.99 M | $5.99 M(+346.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $1.34 M(-71.0%) |
| Jun 2022 | - | $4.62 M(+57.7%) |
| Mar 2022 | - | $2.93 M(+315.2%) |
| Dec 2021 | $706.00 K(-55.9%) | $706.00 K(-69.0%) |
| Sep 2021 | - | $2.28 M(+21.1%) |
| Jun 2021 | - | $1.88 M(+17.4%) |
| Dec 2020 | $1.60 M(+125.6%) | $1.60 M |
| Dec 2019 | $710.00 K | - |
FAQ
- What is Entrada Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Entrada Therapeutics?
- What is Entrada Therapeutics annual accounts payable year-on-year change?
- What is Entrada Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Entrada Therapeutics?
- What is Entrada Therapeutics quarterly accounts payable year-on-year change?
What is Entrada Therapeutics annual accounts payable?
The current annual accounts payable of TRDA is $3.28 M
What is the all time high annual accounts payable for Entrada Therapeutics?
Entrada Therapeutics all-time high annual accounts payable is $5.99 M
What is Entrada Therapeutics annual accounts payable year-on-year change?
Over the past year, TRDA annual accounts payable has changed by -$2.71 M (-45.29%)
What is Entrada Therapeutics quarterly accounts payable?
The current quarterly accounts payable of TRDA is $1.29 M
What is the all time high quarterly accounts payable for Entrada Therapeutics?
Entrada Therapeutics all-time high quarterly accounts payable is $6.47 M
What is Entrada Therapeutics quarterly accounts payable year-on-year change?
Over the past year, TRDA quarterly accounts payable has changed by +$540.00 K (+71.81%)